|
biomarkers |
6 |
|
microrna |
6 |
|
pediatric cardiology |
6 |
|
ventricular function |
6 |
|
adenine - analogs and derivatives - metabolism - pharmacology |
5 |
|
camp |
5 |
|
coronary vessels - anatomy and histology - drug effects - metabolism |
5 |
|
genistein |
5 |
|
genistein - metabolism - pharmacology |
5 |
|
induced pluripotent stem cells |
5 |
|
muscle, smooth, vascular - drug effects - metabolism |
5 |
|
protein kinase a |
5 |
|
protein kinase inhibitors - metabolism - pharmacology |
5 |
|
relaxation |
5 |
|
vascular smooth muscle |
5 |
|
action potential |
4 |
|
calcium handling |
4 |
|
calcium signaling |
4 |
|
cardiomyocytes cms |
4 |
|
cell stretch |
4 |
|
dilated cardiomyopathy |
4 |
|
engineered cardiac tissue |
4 |
|
human induced pluripotent stem cells |
4 |
|
maturation |
4 |
|
pluripotent stem cell-derived cardiomyocytes |
4 |
|
pumpsodium/calcium exchanger |
4 |
|
serca pump |
4 |
|
tissue engineering |
4 |
|
triiodothyronine |
4 |
|
trpv4 channel |
4 |
|
17β-estradiol |
3 |
|
17β-oestradiol |
3 |
|
adenylate cyclase - metabolism |
3 |
|
anisotropy |
3 |
|
arrhythmias |
3 |
|
autophagy |
3 |
|
camp-dependent protein kinase |
3 |
|
cardiac |
3 |
|
cardiotoxicity |
3 |
|
caveolae |
3 |
|
cgmp |
3 |
|
cgmp-dependent protein kinase, porcine coronary artery |
3 |
|
contraction |
3 |
|
coronary heart disease |
3 |
|
cyclic gmp-dependent protein kinases - metabolism |
3 |
|
endothelium |
3 |
|
estradiol - pharmacology |
3 |
|
estrogen |
3 |
|
gender |
3 |
|
glucose starvation |
3 |
|
hormone replacement therapy |
3 |
|
human embryonic stem cell-derived cardiomyocytes |
3 |
|
human embryonic stem cells |
3 |
|
hypoplastic right heart syndrome |
3 |
|
isoproterenol |
3 |
|
mesenteric artery, superior - drug effects - enzymology |
3 |
|
myocytes |
3 |
|
myocytes, cardiac |
3 |
|
non-genomic |
3 |
|
non-genomic effects |
3 |
|
nongenomic |
3 |
|
pkg |
3 |
|
po lycystin-2 |
3 |
|
pulmonary atresia with intact ventricular septum |
3 |
|
rat mesenteric arteries |
3 |
|
reentry |
3 |
|
ryanodine receptor |
3 |
|
single cell transcriptomics |
3 |
|
vascular reactivity |
3 |
|
vasodilator agents - pharmacology |
3 |
|
ventricular cardiomyocytes |
3 |
|
anticancer therapy |
2 |
|
apoptosis |
2 |
|
blood-vessels - pathophysiology |
2 |
|
blood-vessels. |
2 |
|
breast cancer |
2 |
|
calcium cell level |
2 |
|
calcium transport |
2 |
|
cardiac muscle cell |
2 |
|
cardiomyocytes |
2 |
|
electrochemical biosensors |
2 |
|
estradiol. |
2 |
|
estrogen receptor |
2 |
|
gelma |
2 |
|
human induced pluripotent cells |
2 |
|
human ipsc‐derived cardiomyocytes |
2 |
|
ipsc-cardiac tissues |
2 |
|
nongenomic vascular effects |
2 |
|
organs-on-a-chip |
2 |
|
organ‐on‐a‐chip |
2 |
|
pharmacogenomics |
2 |
|
printing |
2 |
|
rats - physiology. |
2 |
|
silk |
2 |
|
testosterone |
2 |
|
vascular smooth muscle. |
2 |
|
cardiac arrhythmia |
1 |
|
long qt syndrome |
1 |
|
repolarization |
1 |
|
short qt syndrome |
1 |
|
wavelength |
1 |
